These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30236644)

  • 1. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
    Xi H; Yang Z; Tatavarti A; Xu W; Fuerst J; Ormes J
    Int J Pharm; 2019 Jan; 554():48-53. PubMed ID: 30236644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spray Encapsulation as a Formulation Strategy for Drug-Based Room Temperature Ionic Liquids: Exploiting Drug-Polymer Immiscibility to Enable Processing for Solid Dosage Forms.
    Stocker MW; Healy AM; Ferguson S
    Mol Pharm; 2020 Sep; 17(9):3412-3424. PubMed ID: 32852215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
    Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y
    Mol Pharm; 2024 Jul; 21(7):3395-3406. PubMed ID: 38836777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pairwise polymer blends for oral drug delivery.
    Marks JA; Wegiel LA; Taylor LS; Edgar KJ
    J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
    Butreddy A
    Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable?
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    J Pharm Sci; 2011 Oct; 100(10):4349-56. PubMed ID: 21630280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.
    Dohrn S; Reimer P; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2721-2733. PubMed ID: 32463685
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
    Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Evaluation of Particle Size Reduction, Salt Formation, and Amorphous Formulation on the Biopharmaceutical Performance of a Weak Base Drug Candidate.
    Zhang W; Jia W; Weitz BW; Ma F; Chen Y; Chiang PC; Hou HH; Nagapudi K
    Mol Pharm; 2023 Nov; 20(11):5888-5900. PubMed ID: 37792707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
    Gosangari S; Dyakonov T
    Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Alternating Current Electrospinning of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) Nanofibers for Dissolution Enhancement: The Importance of Solution Conductivity.
    Balogh A; Farkas B; Pálvölgyi Á; Domokos A; Démuth B; Marosi G; Nagy ZK
    J Pharm Sci; 2017 Jun; 106(6):1634-1643. PubMed ID: 28257818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability enhancement of β-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion.
    Liu C; Liu Z; Chen Y; Chen Z; Chen H; Pui Y; Qian F
    Eur J Pharm Biopharm; 2018 Mar; 124():73-81. PubMed ID: 29305142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
    Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
    J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.